SI1490049T1 - Citalopram za zdravljenje povisanega krvnega tlaka - Google Patents

Citalopram za zdravljenje povisanega krvnega tlaka

Info

Publication number
SI1490049T1
SI1490049T1 SI200330354T SI200330354T SI1490049T1 SI 1490049 T1 SI1490049 T1 SI 1490049T1 SI 200330354 T SI200330354 T SI 200330354T SI 200330354 T SI200330354 T SI 200330354T SI 1490049 T1 SI1490049 T1 SI 1490049T1
Authority
SI
Slovenia
Prior art keywords
blood pressure
citalopram
treatment
elevated blood
elevated
Prior art date
Application number
SI200330354T
Other languages
English (en)
Slovenian (sl)
Inventor
Psl S Gabor
Original Assignee
Egis Gyogyeszergyar Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyeszergyar Rt filed Critical Egis Gyogyeszergyar Rt
Publication of SI1490049T1 publication Critical patent/SI1490049T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Dental Preparations (AREA)
SI200330354T 2002-03-14 2003-03-13 Citalopram za zdravljenje povisanega krvnega tlaka SI1490049T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0200980A HU0200980D0 (enExample) 2002-03-14 2002-03-14
PCT/HU2003/000021 WO2003075914A1 (en) 2002-03-14 2003-03-13 Citalopram for the treatment of elevated blood pressure
EP03743933A EP1490049B1 (en) 2002-03-14 2003-03-13 Citalopram for the treatment of elevated blood pressure

Publications (1)

Publication Number Publication Date
SI1490049T1 true SI1490049T1 (sl) 2006-10-31

Family

ID=89980266

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330354T SI1490049T1 (sl) 2002-03-14 2003-03-13 Citalopram za zdravljenje povisanega krvnega tlaka

Country Status (34)

Country Link
US (1) US7141604B2 (enExample)
EP (1) EP1490049B1 (enExample)
JP (1) JP2005519945A (enExample)
KR (1) KR100718368B1 (enExample)
CN (1) CN1259912C (enExample)
AT (1) ATE324887T1 (enExample)
AU (1) AU2003211195B2 (enExample)
BG (1) BG108904A (enExample)
BR (1) BR0303384A (enExample)
CA (1) CA2459834A1 (enExample)
CY (1) CY1106129T1 (enExample)
CZ (1) CZ2004661A3 (enExample)
DE (1) DE60305018T2 (enExample)
DK (1) DK1490049T3 (enExample)
EA (1) EA008350B1 (enExample)
EE (1) EE200400069A (enExample)
ES (2) ES2238939B2 (enExample)
HR (1) HRP20040165B1 (enExample)
HU (1) HU0200980D0 (enExample)
IL (2) IL160486A0 (enExample)
IS (1) IS2392B (enExample)
LT (1) LT5255B (enExample)
LV (1) LV13281B (enExample)
MX (1) MXPA04008919A (enExample)
NO (1) NO20034998D0 (enExample)
PL (1) PL368902A1 (enExample)
PT (1) PT1490049E (enExample)
SI (1) SI1490049T1 (enExample)
SK (1) SK2222004A3 (enExample)
TR (1) TR200401036T1 (enExample)
UA (1) UA77506C2 (enExample)
WO (1) WO2003075914A1 (enExample)
YU (1) YU91203A (enExample)
ZA (1) ZA200408056B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06004029A (es) * 2003-10-10 2006-06-28 Solvay Pharm Gmbh Composicion farmaceutica que comprende un agonista del receptor de imidazolina selectivo i1 y un bloqueante del receptor de angiotensina ii.
DE102004002638A1 (de) * 2004-01-19 2005-08-18 Merck Patent Gmbh Kombinationen von Serotonin-Wiederaufnahme-Hemmern und Imidazolin-I2-Agonisten
EP2008653A1 (de) * 2007-06-28 2008-12-31 Charité-Universitätsmedizin Berlin Serotonerge Verbindungen zur Behandlung neuronaler Krankheiten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552012A (en) 1975-12-16 1979-09-05 Du Pont Canada Process for the treatment of comminuted oats
JP3526581B2 (ja) * 1997-07-08 2004-05-17 ハー・ルンドベック・アクティーゼルスカブ シタロプラムの製造方法
CN1286687A (zh) * 1997-11-11 2001-03-07 H·隆德贝克有限公司 制备西酞普兰的方法
US6333357B1 (en) * 1999-11-05 2001-12-25 Be Able, Llc Behavior chemotherapy

Also Published As

Publication number Publication date
US7141604B2 (en) 2006-11-28
MXPA04008919A (es) 2004-11-26
IL160486A (en) 2008-06-05
ES2238939A1 (es) 2005-09-01
AU2003211195A2 (en) 2003-09-22
LT2004049A (en) 2005-03-25
DE60305018D1 (de) 2006-06-08
HRP20040165A2 (en) 2004-10-31
LV13281B (en) 2005-09-20
UA77506C2 (en) 2006-12-15
DE60305018T2 (de) 2006-11-30
EA200401147A1 (ru) 2005-02-24
HU0200980D0 (enExample) 2002-05-29
ATE324887T1 (de) 2006-06-15
BG108904A (en) 2006-04-28
ZA200408056B (en) 2005-10-10
WO2003075914A1 (en) 2003-09-18
JP2005519945A (ja) 2005-07-07
DK1490049T3 (da) 2006-08-21
HK1075390A1 (en) 2005-12-16
CY1106129T1 (el) 2011-06-08
LT5255B (lt) 2005-08-25
US20050065209A1 (en) 2005-03-24
HRP20040165B1 (hr) 2007-08-31
IS2392B (is) 2008-08-15
EP1490049A1 (en) 2004-12-29
ES2263009T3 (es) 2006-12-01
EA008350B1 (ru) 2007-04-27
IL160486A0 (en) 2004-07-25
CN1259912C (zh) 2006-06-21
EE200400069A (et) 2004-08-16
PT1490049E (pt) 2006-08-31
PL368902A1 (en) 2005-04-04
SK2222004A3 (en) 2004-08-03
CA2459834A1 (en) 2003-09-18
YU91203A (sh) 2006-08-17
TR200401036T1 (tr) 2005-10-21
CN1568183A (zh) 2005-01-19
KR20040090949A (ko) 2004-10-27
AU2003211195B2 (en) 2007-10-18
EP1490049B1 (en) 2006-05-03
IS7418A (is) 2004-08-20
BR0303384A (pt) 2004-03-30
AU2003211195A1 (en) 2003-09-22
CZ2004661A3 (cs) 2004-10-13
ES2238939B2 (es) 2006-04-16
NO20034998D0 (no) 2003-11-10
KR100718368B1 (ko) 2007-05-14

Similar Documents

Publication Publication Date Title
MY127290A (en) New use of flibanserin
MXPA05004247A (es) Cromonas y derivados de cromona y usos de los mismos.
AU2003297048A1 (en) Cyclohexyl compounds as ccr5 antagonists
WO2004043341A3 (en) Treatment for hemorrhagic shock
WO2004030611A3 (en) Non-nucleoside reverse transcriptase inhibitors
AU2003296992A1 (en) Pyrrolidine and azetidine compounds as ccr5 antagonists
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
PL372457A1 (en) New pharmaceutical compositions containing flibanserin polymorph a
MXPA03010761A (es) Combinaciones farmaceuticas.
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
IL157065A0 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
MXPA04001847A (es) Uso de sistemas de indan-1-ol polisbstituidos para producir drogas utilizadas en la profilaxis o tratamiento de la obesidad.
HRP20040165A2 (en) Citalopram for the treatment of elevated blood pressure
UA83017C2 (uk) Комбінація рофлуміласту та r,r-формотеролу для лікування захворювань дихальних шляхів
WO2004073627A3 (en) Novel therapeutic method and compositions for topical administration
MXPA03010919A (es) Uso de acetil l-carnitina para preparacion de medicamento para terapia preventiva del dolor.
PL367628A1 (en) Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia
WO2004078761A8 (en) Enantiomerically pure cilazapril,process for preparation
WO2002094377A3 (de) Physiologisch verträgliche kalium- und magnesiumsalze enthaltendes pharmazeutisches präparat und verwendung davon zur therapie von qt-zeitverlängerungen
MXPA03010350A (es) Uso de un gatran para la elaboracion de un medicamento para el tratamiento de fibrosis pulmonar.
TW200519078A (en) 2-alkylidene-19-nor-vitamin d derivatives for the treatment of a second hip fracture